As of May 13
| 0.00 / 0.00%|
The 21 analysts offering 12-month price forecasts for CSPC Pharmaceutical Group Ltd have a median target of 54.17, with a high estimate of 61.26 and a low estimate of 43.81. The median estimate represents a +30.41% increase from the last price of 41.54.
The current consensus among 21 polled investment analysts is to Buy stock in CSPC Pharmaceutical Group Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.